2 October 2020
An interim clinical commissioning policy has been in place across the UK since 3 July 2020, defining routine access to remdesivir in the treatment of COVID-19 in adults and children aged 12 years or older. However, due to increased demand against available supply, clinicians are now asked to apply t...
25 September 2020
Two new reports have been released outlining the findings of a snapshot survey of the UK's general paediatric and neonatal services and workforce in September 2019. The reports provide a pre-COVID benchmark and give recommendations to government, service planners and other decision makers about how ...
9 September 2020
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.
8 September 2020
Consultant Paediatrician Dr Prabhu Rajendran tell us why being an RCPCH Ambassador is so important to him and gives a snapshot of the work he undertakes in this role.
27 August 2020
David James tells us how he balances an acute specialty with a healthy work life balance - and how a bit of cycling helps, too!
14 July 2020
The UK must prepare now for a potential new wave of coronavirus infections this winter that could be more serious than the first, says a new report from the Academy of Medical Sciences. Responding to 'Preparing for a challenging winter', the RCPCH made the following statement on vaccinations and pro...
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
3 June 2020
RCPCH is placing children and young people’s voice at the heart of COVID-19 recovery planning by showcasing the experiences and insight from under 25s across the UK.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
5 March 2020
Every death of a child or young person is a unique tragedy. In coping with such events as healthcare professionals, we respond in personalised ways. A common question, though, is whether we did everything we could to prevent it. Did we examine thoroughly? Did we respond to results quickly? Did we li...